Eshelman Ventures, Llc - Net Worth and Insider Trading
Eshelman Ventures, Llc Net Worth
The estimated net worth of Eshelman Ventures, Llc is at least $53 Million dollars as of 2024-09-20. Eshelman Ventures, Llc is the 10% Owner of Liquidia Corp and owns about 2,776,783 shares of Liquidia Corp (LQDA) stock worth over $29 Million. Eshelman Ventures, Llc is also the 10% Owner of G1 Therapeutics Inc and owns about 3,439,151 shares of G1 Therapeutics Inc (GTHX) stock worth over $25 Million. Details can be seen in Eshelman Ventures, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eshelman Ventures, Llc has not made any transactions after 2021-01-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eshelman Ventures, Llc
Eshelman Ventures, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eshelman Ventures, Llc owns 3 companies in total, including Aravive Inc (ARAV) , Liquidia Corp (LQDA) , and G1 Therapeutics Inc (GTHX) .
Click here to see the complete history of Eshelman Ventures, Llc’s form 4 insider trades.
Insider Ownership Summary of Eshelman Ventures, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARAV | Aravive Inc | 2020-04-08 | director |
| LQDA | Liquidia Corp | 2021-01-26 | 10 percent owner |
| GTHX | G1 Therapeutics Inc | 2017-05-22 | 10 percent owner |
Eshelman Ventures, Llc Latest Holdings Summary
Eshelman Ventures, Llc currently owns a total of 2 stocks. Among these stocks, Eshelman Ventures, Llc owns 2,776,783 shares of Liquidia Corp (LQDA) as of January 26, 2021, with a value of $29 Million and a weighting of 53.7%. Eshelman Ventures, Llc also owns 3,439,151 shares of G1 Therapeutics Inc (GTHX) as of May 22, 2017, with a value of $25 Million and a weighting of 46.3%.
Latest Holdings of Eshelman Ventures, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LQDA | Liquidia Corp | 2021-01-26 | 2,776,783 | 10.27 | 28,517,561 |
| GTHX | G1 Therapeutics Inc | 2017-05-22 | 3,439,151 | 7.15 | 24,589,930 |
Holding Weightings of Eshelman Ventures, Llc
Eshelman Ventures, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Eshelman Ventures, Llc has made a total of 20 transactions in Liquidia Corp (LQDA) over the past 5 years, including 4 buys and 16 sells. The most-recent trade in Liquidia Corp is the sale of 1,762,162 shares on January 26, 2021, which brought Eshelman Ventures, Llc around $5 Million.
According to the SEC Form 4 filings, Eshelman Ventures, Llc has made a total of 0 transactions in G1 Therapeutics Inc (GTHX) over the past 5 years. The most-recent trade in G1 Therapeutics Inc is the acquisition of 300,000 shares on May 22, 2017, which cost Eshelman Ventures, Llc around $5 Million.
Insider Trading History of Eshelman Ventures, Llc
- 1
Eshelman Ventures, Llc Trading Performance
GuruFocus tracks the stock performance after each of Eshelman Ventures, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eshelman Ventures, Llc is 26.67%. GuruFocus also compares Eshelman Ventures, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eshelman Ventures, Llc within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eshelman Ventures, Llc's insider trading performs compared to the benchmark.
Performance of Eshelman Ventures, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.33 | | | | | |
| Relative Return to S&P 500(%) | -9.27 | | | | | |
Eshelman Ventures, Llc Ownership Network
Eshelman Ventures, Llc Owned Company Details
What does Aravive Inc do?
Who are the key executives at Aravive Inc?
Eshelman Ventures, Llc is the director of Aravive Inc. Other key executives at Aravive Inc include Chief Commercial Officer Maria Carolina Petrini , Chief Medical Officer Robert B. Geller , and Chief Financial Officer Rudy Howard .
Aravive Inc (ARAV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aravive Inc Insider Transactions
Eshelman Ventures, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Eshelman Ventures, Llc. You might contact Eshelman Ventures, Llc via mailing address: 319 N. 3rd Street, Suite 301, Wilmington Nc 28401.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
